BETNESOL

Dosage : Tablet, Injection, Oral drops
Contains : Betamethasone Sodium Phosphate Tablets I.P. 0.5 mg / 1.0 mg
Category : Corticosteroids
Uses : Inflammation, severe allergies
Price :

Betnesol contains betamethasone, a corticosteroid. Corticosteroids have multiple actions which produce anti-inflammatory effects and result in their widespread use for treating diseases.

 

A wide variety of diseases may sometimes require corticosteroid therapy. Some of the principal indications of Betnesol are:

  • Bronchial asthma
  • Severe hypersensitivity reactions
  • Anaphylaxis
  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Dermatomyositis
  • Mixed connective tissue disease (excluding systemic sclerosis)
  • Polyarteritis nodosa
  • Inflammatory skin disorders, including pemphigus vulgaris
  • Bullous pemphigoid
  • Pyoderma gangrenosum
  • Minimal change nephrotic syndrome
  • Acute interstitial nephritis
  • Ulcerative colitis
  • Crohn’s disease
  • Sarcoidosis
  • Haemolytic anaemia (autoimmune)
  • Acute and lymphoblastic and chronic lymphocytic leukaemia
  • Malignant lymphoma
  • Multiple myeloma
  • Idiopathic thrombocytopenic purpura
  • Immunosuppression in transplantation
  • Rheumatic carditis

 

Betnesol is a brand from GlaxoSmithkline, which is the world’s leading research based pharmaceutical, healthcare and vaccine company. Through its accomplished and dedicated workforce, GSK applies its expertise to innovate various medicines that contributes to the health and well-being of the people of all generations around the world. The company is committed to improve the quality of human life by enabling people to do more, feel better and live longer.

Anaphylaxis

 

Some types of allergies, including allergies to foods and insect stings, can trigger a severe reaction known as anaphylaxis. A life-threatening medical emergency, anaphylaxis can cause you to go into shock. Signs and symptoms of anaphylaxis include:

  • Loss of consciousness
  • A drop in blood pressure
  • Severe shortness of breath
  • Skin rash
  • Lightheadedness
  • A rapid, weak pulse
  • Nausea and vomiting

Dosage

As directed by your Physician

Administration

As directed by your Physician

Adverse Reactions/ Side Effects

Suppression of HPA axis, growth suppression especially in children, menstrual irregularity and amenorrhoea, Cushingoid facies, hirsutism, weight gain, impaired carbohydrate tolerance, increased appetite, hyperhidrosis; recurrence of dormant TB, opportunistic infections; osteoporosis, vertebral and long bone fractures, avascular osteonecrosis, tendon rupture, proximal myopathy; Na and water retention, HTN, K loss, hypokalaemic alkalosis; affective disorder (e.g. irritable, euphoric, depressed and labile mood, suicidal thoughts), psychotic reactions ( e.g. mania, delusions, hallucinations and aggravation of schizophrenia), behavioural disturbances.

 

Also, irritability, anxiety, sleep disturbances and cognitive dysfunction (e.g. confusion, amnesia), epilepsy aggravation; increased intraocular pressure, glaucoma, papilloedema, posterior subcapsular cataracts, corneal or scleral thinning, exacerbation of ophth viral or fungal disease; abdominal distension, oesophageal ulceration, nausea, dyspepsia, peptic ulceration w/ perforation and haemorrhage, acute pancreatitis, candidiasis; impaired healing, skin atrophy, bruising, telangiectasia, striae, acne, Stevens-Johnson syndrome; thrombo-embolism, malaise, hiccups.

Warnings and Precautions

Patient w/ history of severe affective disorder esp steroid psychosis, osteoporosis, CHF or HTN, recent MI, DM, history of TB, glaucoma, corticosteroid-induced myopathy, epilepsy, peptic ulceration, hypothyroidism, myasthenia gravis; psoriasis (topical). Renal and hepatic impairment. Children. Pregnancy and lactation. Patient Counselling Avoid abrupt withdrawal. Avoid exposure to chickenpox or measles. Monitoring Parameters for hypothalamic-pituitary-adrenal (HPA) axis suppression, especially in children.

Contraindications

Untreated infections (systemic and topical). Idiopathic thrombocytopenic purpura (IM).

Drug Interactions

Increased plasma concentration when used w/ CYP3A4 inhibitors (e.g. ritonavir, itraconazole), and OCs. Decreased therapeutic effect when concurrently used w/ rifampicin, rifabutin, carbamazepine, phenobarbitone, phenytoin, primidone, aminoglutethimide and ephedrine. May antagonise the effect of hypoglycaemic agents, antihypertensives, neuromuscular blockers (e.g. vecuronium), and diuretics. Increased risk of hypokalaemia w/ acetazolamide, loop/thiazide diuretics, carbenoxolone, theophylline, cardiac glycosides.

 

May inhibit the growth promoting effects of somatropin. Increased risk of tendon rupture w/ concurrent use of fluoroquinolones. May increase the metabolism of quetiapine and tretinoin. Increased risk of GI bleeding when used w/ NSAIDs. May enhance the efficacy of coumarin anticoagulants.

Overdosage

–

Storage

Intramuscular: Store between 15-30°C. Nasal: Store between 15-30°C. Ophthalmic: Store between 15-30°C. Oral: Store between 15-30°C. Otic/Aural: Store between 15-30°C. Parenteral: Store between 15-30°C. Topical/Cutaneous: Store between 15-30°C.

Mechanism of Action

Betamethasone is a corticosteroid w/ mainly glucocorticoid activity. It induces phospholipase A2inhibitory lipase (lipocortins) and sequentially inhibits the release of arachidonic acid, thereby depressing the formation, release, and activity of prostaglandins, leukotrienes, and other inflammatory mediators.

References

https://www.mayoclinic.org/diseases-conditions/allergies/symptoms-causes/syc-20351497

https://india-pharma.gsk.com/media/701078/betnesol-tablet-and-betnesol-forte-tablets.pdf

If you are a healthcare practitioner and want additional material on the brand, disease, or molecule we have a few articles that can be hand-delivered by the company representative to you directly.

MEDIA

NEED FURTHER INFO?